MTOR and melanoma: Werzoma and colleagues were able to show that either targeting phosphoinositide 3-kinase (PI-3K) or mammalian target of rapamycin (mTOR) was sufficient to induce melanoma cell apoptosis, but when dual targeted these inhibitors resulted in a synergistic suppression of cellular proliferation.